Product category:
Nucleic acid sequencing and synthesis
News Release from: GE Healthcare | Subject: Redivue Tip
Edited by the Laboratorytalk Editorial
Team on 18 April 2003
Tips to improve radiochemical safety
Contains reaction-sized aliquots of radionucleotide in a solution-free format, making experiments easier and safer to do
Amersham Biosciences has enhanced its Redivue range to further improve the safety and efficiency of radiochemical use in laboratories The new Redivue Tip [a-32P] dCTP contains reaction-sized aliquots of radionucleotide in a solution-free format, making experiments easier and safer to do
This article was originally published on Laboratorytalk on 25 Apr 2003 at 8.00am (UK)
Related stories
20,000 human genes in a single experiment
Bioarray can be used to identify up or down regulated genes involved in key biological processes including oncogenesis, metabolism, inflammation and apoptosis
Cassettes for high performance ultrafiltration
Help to speed up bioprocessing timelines by offering an easy way to separate, concentrate and diafilter biological solutions
The preloaded Redivue Tip will enable those in industrial screening and academic bench laboratories to work with increased safety and efficiency.
The radionucleotide is reversibly immobilised on to the interior surface of the pipette tip for elution directly into the reaction mixture.
The risk of spillage is minimised, and the highly visible Redivue dye aids handling.
Any radioactive spillages that do occur can be seen clearly and dealt with safely.
In addition, with the radioactivity already supplied in a pipette tip, there is less product and packaging waste.
Users will also find it easy to see how many tips are left, and an activity calculator is supplied making record keeping easy and accurate - even with multiple users.
The new Redivue Tip will be used primarily for the labelling of DNA.
Due to its innovative product design, Redivue Tip does not contain any chemical stabilisers and can still be stored at 40C with no compromise on performance in a range of applications.
Cathy Howat, vice president for marketing bioassays at Amersham Biosciences, said, "The launch of Redivue Tip demonstrates our ongoing commitment to innovation, particularly in an important market such as the radiochemical industry.
Radioactivity is still the method of choice for many organisations that have established protocols where the sensitivity of radioactivity simply cannot be matched by new technologies.
Redivue Tip will appeal to researchers because it increases the efficiency of their radiological experiments." Redivue Tip will also be of interest to radiation protection officers whose role it is to promote and advocate safety in the laboratory.".
• GE Healthcare: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
